Correlation Between NewAmsterdam Pharma and Takeda Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NewAmsterdam Pharma and Takeda Pharmaceutical Co, you can compare the effects of market volatilities on NewAmsterdam Pharma and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and Takeda Pharmaceutical.

Diversification Opportunities for NewAmsterdam Pharma and Takeda Pharmaceutical

-0.58

Correlation Coefficient

NewAmsterdam Pharma  Takeda Pharmaceutical

Excellent diversification

The 3 months correlation between NewAmsterdam and Takeda is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and Takeda Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and Takeda Pharmaceutical go up and down completely randomly.

Pair Corralation between NewAmsterdam Pharma and Takeda Pharmaceutical

Given the investment horizon of 90 days NewAmsterdam Pharma is expected to under-perform the Takeda Pharmaceutical. In addition to that, NewAmsterdam Pharma is 2.03 times more volatile than Takeda Pharmaceutical Co. It trades about -0.37 of its total potential returns per unit of risk. Takeda Pharmaceutical Co is currently generating about 0.25 per unit of volatility. If you would invest  1,335  in Takeda Pharmaceutical Co on November 28, 2024 and sell it today you would earn a total of  101.00  from holding Takeda Pharmaceutical Co or generate 7.57% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

NewAmsterdam Pharma  vs.  Takeda Pharmaceutical Co

NewAmsterdam Pharma

Risk-Adjusted Performance

Very Weak

Over the last 90 days NewAmsterdam Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable primary indicators, NewAmsterdam Pharma is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Takeda Pharmaceutical

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Takeda Pharmaceutical Co are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Takeda Pharmaceutical is not utilizing all of its potentials. The newest stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with NewAmsterdam Pharma and Takeda Pharmaceutical

The main advantage of trading using opposite NewAmsterdam Pharma and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.

The idea behind NewAmsterdam Pharma and Takeda Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.